homeWelcome, sign in or click here to subscribe.login
     


 

 

Business


print  email to a friend  reprints add to mydjc  

November 30, 2017

Juno Therapeutics

Juno Therapeutics, a Seattle biopharmaceutical company developing immunotherapies for treating cancer, named Ann L. Lee, Ph.D., executive vice president of technical operations. Dr. Patrick Y. Yang will assume the role of executive vice president and senior advisor to the CEO. Both will report to Hans Bishop, president and CEO. Lee held senior positions at RocheGenentech and Merck & Co.




Email or user name:
Password:
 
Forgot password? Click here.